Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.23 USD | +1.84% | +5.12% | +5.69% |
Mar. 28 | Bristol Myers Squibb Drug Misses Endpoint in Crohn's Disease Trial | DJ |
Mar. 28 | Bristol-Myers Squibb's Phase 3 Trial of Crohn's Disease Treatment Fails to Meet Primary Endpoint | MT |
Filters
- Stock
- Equities
- Stock Bristol-Myers Squibb Company - Nyse
- News Bristol-Myers Squibb Company